A cyclophosphamide-based regimen better protects against GVHD after an allogeneic stem cell transplant than the standard therapy in people with blood cancers.
Preventing GVHD after a Stem Cell Transplant
Posted in biotech/medical
Posted in biotech/medical
A cyclophosphamide-based regimen better protects against GVHD after an allogeneic stem cell transplant than the standard therapy in people with blood cancers.